Eric Lefkofsky is an American entrepreneur who has started and led several technology firms. Now based in the greater Chicago area, he was born in Detroit, Michigan in 1969. His father was a structural engineer and his mother taught at a local school. He graduated from Southfield-Lathrup High School and then attended the University of Michigan. He has a bachelor’s degree from that university and also earned a law degree there.
He is worth an estimated $2.4 billion. Eric Lefkofsky made a large amount of this money from Groupon which he co-founded in January 2007. Among other companies he has co-founded with a longtime business partner are Echo Global Logistics, InnerWorkings, Lightbank, and MediaBank. He has led some of these companies as their chief executive officer and has also been a chairman of the board of directors.
His latest company is Tempus, Inc. This company has built a database that collected and organized data to help cancer doctors treat their patients. The data is made up of genomic sequencing of past cancer patients, doctors notes, x-rays, and other information collected when someone is undergoing cancer treatment.
At Tempus they take a data-first mentality. Clinical and molecular data is run through a machine learning platform that is designed to help doctors make more informed decisions when deciding what treatment is best for their patient with cancer. Eric Lefkofsky says that their platform is now being used across the United States in hospitals including the Cleveland Clinic and the Mayo Clinic. He said that they are now looking to possibly expand internationally in the near future.
Along with his wife, Eric Lefkosky established a family foundation in order to financially support a wide variety of causes. The main types of causes they provide funding to include education, medicine, arts and culture, and human rights. They support nonprofits in both the United States and around the world. In 2013, this couple also joined the Giving Pledge which is a campaign that encourages billionaires to donate most of their wealth to charity.
Contact Eric Lefkofsky: adrinkwith.com/eric-lefkofsky/
It’s another scheduled procedure that you have been dreading since the last time your shadow landed on the hospital doorstep. The procedure itself is simple enough, they insert an IV and the chemicals slowly flow into your bloodstream with a fiery presence that ensures that they are working, almost too well. It is mainly the effects after the appointment where the real struggle begins. It starts with appetite loss, nausea, fatigue, hair loss and photo-sensitivity all hubs around a constant writhing pain throughout your whole body. This is the one of the most common treatments for cancer known as chemotherapy and it has some people saying that it worse than the cancer that it treats.
Dr. Clay Siegall has made it his life’s goal to discover more targeting methods to treating cancer that do not result to such dramatic side effects. With his education in a B.S. of zoology from the University of Maryland and a PhD in genetics from George Washington University, he is utilizing all that he knows to bring to fruition the future of improved cancer treatments that also lowers the mortality rate of the cancer as well. He has been the founder and CEO of Seattle Genetics since 1998 and has quickly risen to the front-line of the industry to promote better drugs through companies such as Bayer, Pfizer, Genentech and etc. With his endeavors the methods of chemotherapy shall be rendered obsolete and will just become a page in the history books.
His inspiration to searching for this more direct approach came from observing the prevalent methods and just how extreme they seemed to be with hardly any real beneficial results, especially in the cases of radical surgery and amputation.
His endeavor has not been without its hardships, it took nearly ten years for the company to actually become profitable and there was a financial crisis in 1999 and 2000 where it was rather uncertain whether the business would survive another fiscal year. They say that you must look at danger in the face and embrace death to actually be able to fight for